Please provide your email address to receive an email when new articles are posted on . Researchers compared the 21-valent ...
The FDA has approved lerodalcibep-liga, a third-generation injectable PCSK9 inhibitor, to reduce LDL cholesterol in adults ...
The FDA has qualified AI-Based Histologic Measurement of NASH, or AIM-NASH — the first AI drug development tool — to assist ...
Delivering essential supportive care services during breast cancer treatment lowered stress and improved quality of life for ...
Women who receive risk-based breast cancer screening recommendations discussed those recommendations with their primary care ...
Patients with chronic spontaneous urticaria experienced relief in itch and hives by day 3 with povorcitinib, according to ...
Use of GLP-1 receptor agonists, which have shown to be effective in diabetes and obesity treatment, is expanding into other ...
Rafael Kramann, MD, PhD, FASN, FERA, embraced the field of nephrology early in his career for the opportunity to take on ...
Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Courtney Cameron, PharmD, BCACP, about widespread availability of ...
In patients with diabetes and multivessel coronary artery disease undergoing percutaneous coronary intervention, ticagrelor ...
A new program for training rheumatology fellows at Louisiana State University may offer a new way to combat the specialty’s ...
In this video, Erika Hamilton, MD, discusses HER2CLIMB-05 trial results demonstrating that the addition of tucatinib to maintenance therapy delayed metastatic breast cancer progression for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback